US

Showing 15 posts of 327 posts found.

opioid_pills

Surgeon General calls for cultural shift in approach to opioid crisis

September 21, 2018
Medical Communications Trump, US, opioid crisis, opioid epidemic, surgeon general

The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk …

white-house-13863_960_720

Senate bill would save money and allow generics to reach market more quickly, according to CBO report

September 20, 2018
Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics

The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …

sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018
Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …

US Senate pass bipartisan bill to tackle opioid crisis

September 18, 2018
Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics

The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …

teva_copy

Teva shares soar after migraine treatment Ajovy approval

September 17, 2018
Sales and Marketing FDA, Teva, US, ajovy, approval, israel

Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …

GSK’s Nucala data insufficient for US COPD approval

September 10, 2018
Sales and Marketing COPD, FDA, GSK, Nucala, US, pharma

GlaxoSmithKline has suffered a regulatory blow in the label expansion of its interleukin-5 (IL5) inhibitor Nucala (mepolizumab), with the FDA …

5204602349_c87b204860_z

FDA recruitment official says Trump’s policies are making hiring difficult

September 7, 2018
Medical Communications FDA, Trump, US, hiring, recruitment

Melanie Keller, Acting Associate Commissioner for Scientific and Clinical Recruitment at the US Food and Drug Administration (FDA) has said …

donald_trump_29496131773

Trump administration resists WHO efforts to tackle antimicrobial resistance

August 31, 2018
Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance

The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …

ipos0_l

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018
Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …

hero-plus

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018
Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …

chris-collins_getty_images

Indicted GOP congressman Chris Collins’ terminates re-election campaign

August 13, 2018
Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma

Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …

fdaoutsideweb

FDA approves first oral therapy for rare Fabry disease

August 13, 2018
Sales and Marketing FDA, Fabry disease, US, pharma

Amicus has revealed that its therapy Galafold (migalastat) has been awarded approval by the FDA in the treatment of adult …

rep

US Congressman arrested over insider trading in biopharma firm

August 9, 2018
Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma

A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …

16792957331_d9572dbdf4_z

FDA expands list of valsartan recalls

August 9, 2018
Medical Communications China, FDA, US, heart medication, recall, valsartan

The US Food and Drug Administration (FDA) has expanded a list of products containing valsartan that are to be recalled. …

AstraZeneca

AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas

August 8, 2018
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma

AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …

The Gateway to Local Adoption Series

Latest content